Let’s break barriers to fight Covid-19 together

Moderna’s COVID-19 Vaccine Candidate Shows Promising Initial Results in Human Trials

Biotech company Moderna declared promising initial results in Phase 1 of its human trials of what could be the first viable vaccine for the virus behind the COVID-19 illness, with a potential release date of early 2021.

Following two doses, every participant in Moderna’s human trials as of writing showed good signs of antibody response to the vaccine — called mRNA-1273 — in Phase 1 of the study led by the National Institutes of Health (NIH), according to the press release.

However, it’s important to note that this small initial study was primarily focused on safety, and as things stand the results don’t conclusively show a vaccine fully capable of preventing potential infection from coronavirus transmission, reports Business Insider.

More information

Notify of